Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
25.30
-0.74 (-2.84%)
Sep 9, 2026, 4:00 PM EDT
SHA:603207 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 537.42 | 525.28 | 474.58 | 471.87 | 456.89 | 401.77 |
Revenue Growth | 11.36% | 10.68% | 0.57% | 3.28% | 13.72% | 11.22% |
Gross Profit Gross Profit Growth | 328.63 | 341.25 | 311.3 | 308.8 | 269.45 | 254.43 |
Operating Income Operating Income Growth | 219.81 | 238.19 | 233.49 | 230.48 | 195.85 | 142.84 |
Net Income Net Income Growth | 192.22 | 207.49 | 205.27 | 203.63 | 175.18 | 126.27 |
Earnings Per Share EPS Growth | 1.20 | 1.29 | 1.53 | 1.70 | 1.46 | 1.05 |
EPS Growth | -10.48% | -15.69% | -10.00% | 16.44% | 39.05% | - |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
East China East China Growth | 182.77 |
North China North China Growth | 69.59 |
South China South China Growth | 85.52 |
Southwest Southwest Growth | 59.12 |
Central China Central China Growth | 58.87 |
Northeast Northeast Growth | 45.23 |
Northwest Northwest Growth | 23.4 |
Overseas Overseas Growth | 0.21 |
Total Total Growth | 524.7 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 674.68 | 647.59 | 883.43 | 288.52 | 168.93 | 208.01 |
Total Debt Total Debt Growth | 9.49 | 2.5 | 2.32 | 0.86 | 0.88 | 1.27 |
Net Cash (Debt) Net Cash Growth | 665.2 | 645.08 | 881.11 | 287.65 | 168.05 | 206.74 |
Net Cash Growth | -5.82% | -26.79% | 206.31% | 71.17% | -18.71% | 83.45% |
Net Cash Per Share Net Cash Per Share Growth | 4.15 | 4.01 | 6.57 | 2.40 | 1.40 | 1.72 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 168.27 | 160.8 | 212.21 | 200.26 | 137.2 | 179.51 |
Capital Expenditures CapEx Growth | -84.9 | -54.24 | -83.94 | -80.15 | -61.59 | -12.48 |
Free Cash Flow Free Cash Flow Growth | 83.37 | 106.56 | 128.27 | 120.11 | 75.61 | 167.03 |
Free Cash Flow Growth | -34.11% | -16.93% | 6.79% | 58.86% | -54.73% | 20.59% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 61.15% | 64.96% | 65.59% | 65.44% | 58.97% | 63.33% |
Operating Margin | 40.90% | 45.35% | 49.20% | 48.84% | 42.86% | 35.55% |
Pretax Margin | 41.55% | 45.92% | 50.47% | 50.26% | 45.10% | 38.47% |
Profit Margin | 35.77% | 39.50% | 43.25% | 43.15% | 38.34% | 31.43% |
FCF Margin | 15.51% | 20.29% | 27.03% | 25.45% | 16.55% | 41.57% |
| Fiscal Year | Current | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Dividend Per Share Dividend Per Share Growth | 1.070 | 1.070 | 1.500 |
Dividend Per Share Growth | 0% | -28.67% | - |
Dividend Yield | 3.83% | 3.80% | 5.82% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.09 | 22.15 | 21.90 | - | - | - |
P/FCF Ratio | 48.76 | 43.13 | 35.04 | - | - | - |
PS Ratio | 7.56 | 8.75 | 9.47 | - | - | - |